We conducted this study to investigate the antioxidant abilities of Magnofluorine using bioassays such as Fe3+ and Cu2+ reduction, DMPD•+, ABTS•+, and DPPH• scavenging abilities and test the purposed inhibitory abilities of Magnofluorine towards BChE, hCA II, AChE, and α-glycosidase associated with glaucoma, AD, and T2DM diseases. The gene discussed is BCHE; the disease is Alzheimer disease.